CA2348779A1 - Detecteurs moleculaires polynucleotidiques a domaines multiples - Google Patents
Detecteurs moleculaires polynucleotidiques a domaines multiples Download PDFInfo
- Publication number
- CA2348779A1 CA2348779A1 CA002348779A CA2348779A CA2348779A1 CA 2348779 A1 CA2348779 A1 CA 2348779A1 CA 002348779 A CA002348779 A CA 002348779A CA 2348779 A CA2348779 A CA 2348779A CA 2348779 A1 CA2348779 A1 CA 2348779A1
- Authority
- CA
- Canada
- Prior art keywords
- domain
- rna
- allosteric
- ligand
- ribozyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
Abstract
L'invention concerne des polynucléotides à domaines multiples, sensibles aux agents de signalisations, configurés et construits de manière à comprendre au moins trois domaines pouvant se chevaucher partiellement, entièrement ou pas du tout, à savoir un domaine activateur (catalytique ou rapporteur), un domaine de pontage et un domaine récepteur. Dans une forme d'exécution caractéristique, un agent de signalisation tel qu'un ligand chimique interagit avec le domaine récepteur, ce qui modifie ou influence d'une autre manière le domaine de pontage de telle façon que la fonction d'activation, catalytique ou rapporteuse du domaine d'actionnement est stimulée ou inhibée. Dans certaines formes à ribozymes par exemple, des détecteurs moléculaires spécifiques du ligand, composés d'ARN, sont créés par couplage du domaine catalytique et du domaine récepteur préexistants au moyen de nouveaux ponts structurels fonctionnant de la manière suivante : la fixation d'un ligand sur le domaine récepteur provoque une modification de la configuration du pont et cette réorganisation structurelle détermine l'activité du ribozyme contigu. L'invention concerne également des procédés permettant une sélection allostérique d'autres polynucléotides à domaines multiples, ces procédés consistant normalement à répartir et à coupler les domaines de manière à favoriser la liaison ou d'autres signaux réponse et/ou l'activité rapporteuse.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10682998P | 1998-11-03 | 1998-11-03 | |
US60/106,829 | 1998-11-03 | ||
US12668399P | 1999-03-29 | 1999-03-29 | |
US60/126,683 | 1999-03-29 | ||
PCT/US1999/025497 WO2000026226A1 (fr) | 1998-11-03 | 1999-10-29 | Detecteurs moleculaires polynucleotidiques a domaines multiples |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2348779A1 true CA2348779A1 (fr) | 2000-05-11 |
Family
ID=26804069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002348779A Abandoned CA2348779A1 (fr) | 1998-11-03 | 1999-10-29 | Detecteurs moleculaires polynucleotidiques a domaines multiples |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1133513A4 (fr) |
JP (1) | JP2002528109A (fr) |
AU (2) | AU772881B2 (fr) |
CA (1) | CA2348779A1 (fr) |
WO (1) | WO2000026226A1 (fr) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034009B2 (en) | 1995-10-26 | 2006-04-25 | Sirna Therapeutics, Inc. | Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
US6482932B1 (en) | 1997-11-05 | 2002-11-19 | Ribozyme Pharmaceuticals, Incorporated | Nucleoside triphosphates and their incorporation into oligonucleotides |
US6617438B1 (en) | 1997-11-05 | 2003-09-09 | Sirna Therapeutics, Inc. | Oligoribonucleotides with enzymatic activity |
US6995259B1 (en) | 1998-10-23 | 2006-02-07 | Sirna Therapeutics, Inc. | Method for the chemical synthesis of oligonucleotides |
IL130606A0 (en) * | 1999-06-23 | 2000-06-01 | Intelligene Ltd | An array of nucleic acid sequence |
US6506887B1 (en) | 1999-07-29 | 2003-01-14 | Somalogic, Incorporated | Conditional-selex |
US7491805B2 (en) | 2001-05-18 | 2009-02-17 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
US7833992B2 (en) | 2001-05-18 | 2010-11-16 | Merck Sharpe & Dohme | Conjugates and compositions for cellular delivery |
WO2002081628A2 (fr) | 2001-04-05 | 2002-10-17 | Ribozyme Pharmaceuticals, Incorporated | Modulation de l'expression genique associee a la proliferation inflammatoire et a la croissance de neurites, par des procedes faisant intervenir l'acide nucleique |
AU2001266917A1 (en) * | 2000-06-15 | 2001-12-24 | Board Of Regents | Allosterically regulated ribozymes |
US20030104520A1 (en) * | 2000-06-15 | 2003-06-05 | Ellington Andrew D. | Regulatable, catalytically active nucleic acids |
US6706474B1 (en) | 2000-06-27 | 2004-03-16 | Board Of Trustees Of The University Of Illinois | Nucleic acid enzyme biosensors for ions |
CA2440367A1 (fr) * | 2000-10-20 | 2002-08-15 | Canji, Inc. | Regulation de l'expression genique au moyen d'aptameres |
US9994853B2 (en) | 2001-05-18 | 2018-06-12 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
EP1572067A4 (fr) | 2001-05-18 | 2009-05-13 | Sirna Therapeutics Inc | Conjugues et compositions pour administration cellulaire |
US7109165B2 (en) | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
US7205399B1 (en) | 2001-07-06 | 2007-04-17 | Sirna Therapeutics, Inc. | Methods and reagents for oligonucleotide synthesis |
US20030219422A1 (en) * | 2001-11-15 | 2003-11-27 | Noxxon Pharma Ag | Allosteric ribozymes and uses thereof |
AU2002357240A1 (en) * | 2001-12-14 | 2003-06-30 | Yale University | Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides |
US7071311B2 (en) | 2002-02-13 | 2006-07-04 | Sirna Therapeutics, Inc. | Antibodies having specificity for 2′-C-allyl nucleic acids |
US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
US6890719B2 (en) | 2002-05-10 | 2005-05-10 | The Board Of Trustess Of The University Of Illinois | Fluorescence based biosensor |
US7534560B2 (en) | 2002-05-10 | 2009-05-19 | The Board Of Trustees Of The University Of Illinois | Simple catalytic DNA biosensors for ions based on color changes |
US20040110235A1 (en) | 2002-07-25 | 2004-06-10 | David Epstein | Regulated aptamer therapeutics |
EP2322535A3 (fr) * | 2002-09-20 | 2011-09-28 | Yale University | Riboswitchs, procedes d'utilisation et compositions a utiliser avec des riboswitchs |
US7612185B2 (en) | 2003-03-07 | 2009-11-03 | The Board Of Trustees Of The University Of Illinois | Nucleic acid biosensors |
EP1622572B1 (fr) | 2003-04-30 | 2017-12-20 | Sirna Therapeutics, Inc. | Conjugues et compositions pour la livraison cellulaire |
US7485419B2 (en) | 2004-01-13 | 2009-02-03 | The Board Of Trustees Of The University Of Illinois | Biosensors based on directed assembly of particles |
US10508277B2 (en) | 2004-05-24 | 2019-12-17 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
US7892734B2 (en) | 2005-08-11 | 2011-02-22 | The Board Of Trustees Of The University Of Illinois | Aptamer based colorimetric sensor systems |
US8313901B2 (en) * | 2005-12-21 | 2012-11-20 | Yale University | Methods and compositions related to the modulation of riboswitches |
US7799554B2 (en) | 2006-03-16 | 2010-09-21 | The Board Of Trustees Of The University Of Illinois | Lateral flow devices |
EP2471809B1 (fr) | 2006-07-11 | 2015-09-02 | University Of Medicine And Dentistry Of New Jersey | Protéines, acides nucléiques codant pour celles-ci et procédés d'utilisation correspondants |
WO2008089248A2 (fr) | 2007-01-19 | 2008-07-24 | The Board Of Trustees Of The University Of Illinois | Substances amphiphiles et vésicules lipidiques fonctionnalisées contenant de telles substances |
US8058415B2 (en) | 2007-04-24 | 2011-11-15 | The Board Of Trustees Of The University Of Illinois | Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes |
US8409800B2 (en) | 2007-07-16 | 2013-04-02 | The Board Of Trustees Of The University Of Illinois | Nucleic acid based fluorescent sensor for copper detection |
US8568690B2 (en) | 2007-07-31 | 2013-10-29 | The Board Of Trustees Of The University Of Illinois | MRI contrast agents and high-throughput screening by MRI |
WO2009045632A2 (fr) | 2007-08-10 | 2009-04-09 | The Board Of Trustees Of The University Of Illinois | Capteur fluorescent à base d'acide nucléique destiné à la détection du mercure |
US8062893B2 (en) | 2008-10-10 | 2011-11-22 | The Board Of Trustees Of The University Of Illinois | Fluorescent sensor for mercury |
SG181904A1 (en) | 2009-12-23 | 2012-07-30 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
EP2600901B1 (fr) | 2010-08-06 | 2019-03-27 | ModernaTX, Inc. | Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale |
ES2737960T3 (es) | 2010-10-01 | 2020-01-17 | Modernatx Inc | Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos |
EP3766975A1 (fr) | 2010-10-29 | 2021-01-20 | Sirna Therapeutics, Inc. | Inhibition au moyen d'interférence arn d'une expression de gène utilisant des acides nucléiques à petit interférent (sina) |
AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
EP3682905B1 (fr) | 2011-10-03 | 2021-12-01 | ModernaTX, Inc. | Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations |
EP2791160B1 (fr) | 2011-12-16 | 2022-03-02 | ModernaTX, Inc. | Compositions de mrna modifiés |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9303079B2 (en) | 2012-04-02 | 2016-04-05 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
AU2013243948A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins associated with human disease |
JP5731016B2 (ja) * | 2012-04-27 | 2015-06-10 | キリン株式会社 | リガンドを高感度に検出する核酸分子並びに該核酸分子のスクリーニング方法および該核酸分子の感度の最適化方法 |
EP4074834A1 (fr) | 2012-11-26 | 2022-10-19 | ModernaTX, Inc. | Arn à terminaison modifiée |
BR112015021791B1 (pt) | 2013-03-08 | 2022-08-30 | Novartis Ag | Compostos de lipídio catiônico e composições de lipídios e farmacêuticas |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
WO2015048744A2 (fr) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucléotides codant des polypeptides de modulation immunitaire |
CA2926218A1 (fr) | 2013-10-03 | 2015-04-09 | Moderna Therapeutics, Inc. | Polynucleotides codant pour un recepteur de lipoproteines de faible densite |
EP4019506A1 (fr) | 2013-12-19 | 2022-06-29 | Novartis AG | Lipides et compositions lipidiques pour l'administration d'agents actifs |
PL3083556T3 (pl) | 2013-12-19 | 2020-06-29 | Novartis Ag | Lipidy i kompozycje lipidowe dla dostarczania środków czynnych |
EP4223285A3 (fr) | 2014-07-16 | 2023-11-22 | Novartis AG | Procédé d'encapsulation d'un acide nucléique dans un hôte de nanoparticules lipidiques |
EP3188760B1 (fr) | 2014-09-05 | 2023-12-06 | Novartis AG | Lipides et compositions lipidiques permettant l'administration de principes actifs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU724627B2 (en) * | 1996-12-19 | 2000-09-28 | Yale University | Bioreactive allosteric polynucleotides |
-
1999
- 1999-10-29 JP JP2000579614A patent/JP2002528109A/ja active Pending
- 1999-10-29 EP EP99958709A patent/EP1133513A4/fr not_active Withdrawn
- 1999-10-29 AU AU16013/00A patent/AU772881B2/en not_active Ceased
- 1999-10-29 WO PCT/US1999/025497 patent/WO2000026226A1/fr active IP Right Grant
- 1999-10-29 CA CA002348779A patent/CA2348779A1/fr not_active Abandoned
-
2004
- 2004-08-11 AU AU2004203816A patent/AU2004203816A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1133513A4 (fr) | 2002-07-03 |
WO2000026226A1 (fr) | 2000-05-11 |
EP1133513A1 (fr) | 2001-09-19 |
AU1601300A (en) | 2000-05-22 |
JP2002528109A (ja) | 2002-09-03 |
AU2004203816A1 (en) | 2004-09-02 |
AU772881B2 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772881B2 (en) | Multidomain polynucleotide molecular sensors | |
Tang et al. | Rational design of allosteric ribozymes | |
Soukup et al. | Allosteric nucleic acid catalysts | |
Famulok et al. | Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy | |
US6451535B1 (en) | Composition containing DNA coding for a ribozyme and an oligonucleotide substrate, and method for measuring transcription rates | |
Jenne et al. | A novel ribozyme with ester transferase activity | |
US6630306B1 (en) | Bioreactive allosteric polynucleotides | |
Soukup et al. | Generating new ligand-binding RNAs by affinity maturation and disintegration of allosteric ribozymes. | |
US20030104520A1 (en) | Regulatable, catalytically active nucleic acids | |
Famulok | Allosteric aptamers and aptazymes as probes for screening approaches | |
Kopylov et al. | Combinatorial chemistry of nucleic acids: SELEX | |
Hirao et al. | Re-creating the RNA world | |
US20040126882A1 (en) | Regulatable, catalytically active nucleic acids | |
US7910710B2 (en) | DNA enzymes | |
Schmidt et al. | RNA double cleavage by a hairpin-derived twin ribozyme | |
US20060121510A1 (en) | Multidomain polynucleotide molecular sensors | |
JP2005533862A (ja) | 調節されたアプタマー治療剤 | |
Koizumi et al. | Allosteric ribozymes sensitive to the second messengers cAMP and cGMP | |
Ellington et al. | Combinatorial methods: aptamers and aptazymes | |
Müller et al. | Sensors made of RNA: tailored ribozymes for detection of small organic molecules, metals, nucleic acids and proteins | |
Young et al. | The role of essential pyrimidines in the hairpin ribozyme-catalysed reaction | |
Silverman | Nucleic acid switches and sensors | |
Zhou et al. | Endowing RNase H-inactive antisense with catalytic activity: 2-5A-morphants | |
US20040219581A1 (en) | pH dependent signaling DNA enzymes | |
Polisky | Progress towards Therapeutic Application of SELEX-derived Aptamers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |